← Open Payments lookup

MELISSA MOODY: Open Payments

NPI 1750505384 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$293,167 in 300 payments from 12 companies in 2025. Trend: 2023 $262,639 · 2024 $229,209 · 2025 $293,167

Speaker / faculty: $218,184Travel & lodging: $26,495Consulting: $24,084Honoraria: $18,425Food & beverage: $5,979
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.116$138,930
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)53$65,763
Otsuka America Pharmaceutical, Inc.53$44,040
ABBVIE INC.25$23,827
Axsome Therapeutics, Inc.17$19,771
E.R. Squibb & Sons, L.L.C.8$280
Alkermes, Inc.13$263
Teva Pharmaceuticals USA, Inc.5$96
Lundbeck LLC4$87
Vanda Pharmaceuticals Inc.3$56

Products named: INGREZZA, CAPLYTA, VRAYLAR, ABILIFY MAINTENA, REXULTI, Auvelity, COBENFY, ARISTADA.

Industry payments across WV — which companies pay providers there.